Your browser doesn't support javascript.
loading
Performance of a Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography-Derived Risk-Stratification Tool for High-risk and Very High-risk Prostate Cancer.
Xiang, Michael; Ma, Ting Martin; Savjani, Ricky; Pollom, Erqi L; Karnes, R Jeffrey; Grogan, Tristan; Wong, Jessica K; Motterle, Giovanni; Tosoian, Jeffrey J; Trock, Bruce J; Klein, Eric A; Stish, Bradley J; Dess, Robert T; Spratt, Daniel E; Pilar, Avinash; Reddy, Chandana; Levin-Epstein, Rebecca; Wedde, Trude B; Lilleby, Wolfgang A; Fiano, Ryan; Merrick, Gregory S; Stock, Richard G; Demanes, D Jeffrey; Moran, Brian J; Huland, Hartwig; Tran, Phuoc T; Martin, Santiago; Martinez-Monge, Rafael; Krauss, Daniel J; Abu-Isa, Eyad I; Alam, Ridwan; Schwen, Zeyad; Pisansky, Thomas M; Choo, C Richard; Song, Daniel Y; Greco, Stephen; Deville, Curtiland; McNutt, Todd; DeWeese, Theodore L; Ross, Ashley E; Ciezki, Jay P; Boutros, Paul C; Nickols, Nicholas G; Bhat, Prashant; Shabsovich, David; Juarez, Jesus E; Chong, Natalie; Kupelian, Patrick A; Rettig, Matthew B; Zaorsky, Nicholas G.
Affiliation
  • Xiang M; Department of Radiation Oncology, University of California, Los Angeles.
  • Ma TM; Department of Radiation Oncology, University of California, Los Angeles.
  • Savjani R; Department of Radiation Oncology, University of California, Los Angeles.
  • Pollom EL; Department of Radiation Oncology, Stanford University, Stanford, California.
  • Karnes RJ; Department of Urology, Mayo Clinic, Rochester, Minnesota.
  • Grogan T; Department of Medicine Statistics Core, David Geffen School of Medicine at UCLA, Los Angeles, California.
  • Wong JK; Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania.
  • Motterle G; Department of Urology, Mayo Clinic, Rochester, Minnesota.
  • Tosoian JJ; Department of Urology, University of Michigan, Ann Arbor.
  • Trock BJ; Department of Urology, Brady Urological Institute, Johns Hopkins University, Baltimore, Maryland.
  • Klein EA; Department of Urology, Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, Ohio.
  • Stish BJ; Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota.
  • Dess RT; Department of Radiation Oncology, University of Michigan, Ann Arbor.
  • Spratt DE; Department of Radiation Oncology, University of Michigan, Ann Arbor.
  • Pilar A; Department of Radiation Oncology, University of Toronto, Toronto, Ontario, Canada.
  • Reddy C; Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio.
  • Levin-Epstein R; Department of Radiation Oncology, University of California, Los Angeles.
  • Wedde TB; Department of Oncology, Oslo University Hospital, Norwegian Radium Hospital, Oslo, Norway.
  • Lilleby WA; Department of Oncology, Oslo University Hospital, Norwegian Radium Hospital, Oslo, Norway.
  • Fiano R; Schiffler Cancer Center, Wheeling Hospital, Wheeling Jesuit University, Wheeling, West Virginia.
  • Merrick GS; Schiffler Cancer Center, Wheeling Hospital, Wheeling Jesuit University, Wheeling, West Virginia.
  • Stock RG; Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York City, New York.
  • Demanes DJ; Department of Radiation Oncology, University of California, Los Angeles.
  • Moran BJ; Prostate Cancer Foundation of Chicago, Westmont, Illinois.
  • Huland H; Martini-Klinik Prostate Cancer Center, University Hospital Hamburg Eppendorf, Hamburg, Germany.
  • Tran PT; Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • Martin S; Department of Oncology, Clínica Universitaria de Navarra, University of Navarra, Pamplona, Spain.
  • Martinez-Monge R; Department of Oncology, Clínica Universitaria de Navarra, University of Navarra, Pamplona, Spain.
  • Krauss DJ; Oakland University William Beaumont School of Medicine, Royal Oak, Michigan.
  • Abu-Isa EI; Department of Radiation Oncology, University of Michigan, Ann Arbor.
  • Alam R; Department of Urology, Brady Urological Institute, Johns Hopkins University, Baltimore, Maryland.
  • Schwen Z; Department of Urology, Brady Urological Institute, Johns Hopkins University, Baltimore, Maryland.
  • Pisansky TM; Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota.
  • Choo CR; Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota.
  • Song DY; Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • Greco S; Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • Deville C; Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • McNutt T; Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • DeWeese TL; Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • Ross AE; Department of Urology, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
  • Ciezki JP; Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio.
  • Boutros PC; Department of Human Genetics, University of California, Los Angeles.
  • Nickols NG; Department of Radiation Oncology, University of California, Los Angeles.
  • Bhat P; Department of Radiation Oncology, Veterans Affairs (VA) Greater Los Angeles Healthcare System, Los Angeles, California.
  • Shabsovich D; Department of Radiation Oncology, University of California, Los Angeles.
  • Juarez JE; Department of Radiation Oncology, University of California, Los Angeles.
  • Chong N; Department of Radiation Oncology, University of California, Los Angeles.
  • Kupelian PA; Department of Radiation Oncology, University of California, Los Angeles.
  • Rettig MB; Department of Radiation Oncology, University of California, Los Angeles.
  • Zaorsky NG; Division of Hematology and Oncology, Department of Medicine, University of California, Los Angeles.
JAMA Netw Open ; 4(12): e2138550, 2021 12 01.
Article in En | MEDLINE | ID: mdl-34902034
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Biomarkers, Tumor / Glutamate Carboxypeptidase II / Nomograms / Positron Emission Tomography Computed Tomography / Clinical Decision Rules / Antigens, Surface Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Humans / Male / Middle aged Language: En Journal: JAMA Netw Open Year: 2021 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Biomarkers, Tumor / Glutamate Carboxypeptidase II / Nomograms / Positron Emission Tomography Computed Tomography / Clinical Decision Rules / Antigens, Surface Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Humans / Male / Middle aged Language: En Journal: JAMA Netw Open Year: 2021 Document type: Article